ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VRPX Virpax Pharmaceuticals Inc

0.6767
-0.0507 (-6.97%)
May 31 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -5.12M-5.9M-7.72M-3.1M-1.65M-3.24M-6.12M-4.68M
Pre Tax Income -5.14M-5.89M-7.64M-2.99M-1.52M-3.11M-6M-4.56M
Net Income -5.14M-5.89M-7.64M-2.99M-1.52M-3.11M-6M-4.56M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -5.14M-5.89M-7.64M-2.99M-1.52M-3.11M-6M-4.56M
EBITDA -5.12M-5.9M-7.72M-3.1M-1.65M-3.24M-6.12M-4.68M
Year End December 30 2023 201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 000000
Operating Income -2.63M-3.18M-4.2M-12.03M-21.85M-15.69M
Pre Tax Income -2.64M-3.31M-4.34M-12.06M-21.65M-15.19M
Net Income -2.64M-3.31M-4.34M-12.06M-21.65M-15.19M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -0.919-1.095-1.38-1.029-1.848-1.297
EBIT -2.63M-3.18M-4.19M-11.96M-21.65M-15.19M
EBITDA -2.63M-3.18M-4.2M-12.03M-21.85M-15.69M